Fig. 7.
CFU-GM after cessation of erythropoietin therapy.
Evolution of marrow (A), spleen (B), and total body (C) CFU-GM 0, 20, and 40 days after cessation of treatment with high doses of rHuEpo, compared to control untreated animals.
CFU-GM after cessation of erythropoietin therapy.
Evolution of marrow (A), spleen (B), and total body (C) CFU-GM 0, 20, and 40 days after cessation of treatment with high doses of rHuEpo, compared to control untreated animals.
